Monterey Bay Labs

Epidermal Delivery Platform Using Natural Micro-injectors

Health Tech & Life Sciences
Non Active, Dec 2017 ceased to operate
Mature Caesarea Founded 2000
Website ↗
Total raised
$9.0M
Last: Series B 2014-02
Stage
Mature
Founded
2000
Headcount
31
HQ
Caesarea
Sector
Health Tech & Life Sciences

About

Monterey Bay Labs, formerly StarletDerma, is a delivery platform company focused on the development of its proprietary InoCyte system for dermatology and skin care. Using a natural, marine-extracted technology, the InoCyte system delivers drugs through the same micro-injectors that sea anemones use when anesthetizing their prey. The InoCyte delivery platform is backed by a strong and broad IP portfolio granted in the United States, Europe, and Asia, and covers topics in marine biology, mass cultivation, formulations, and methods for production of micro-injectors for active topical delivery. Monterey Bay Labs Inc is registered in Delaware, Maryland, and is a fully owned R&D subsidiary of Monterey Bay Labs Ltd (Israel), located in Caesarea Industrial Park.

Funding history · 1 round · $9.0M total

2014-02
Series B $9.0M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary focus of Monterey Bay Labs?
Monterey Bay Labs is a delivery platform company that develops its proprietary InoCyte system for dermatology and skin care, utilizing natural micro-injectors.
When did Monterey Bay Labs cease operations?
Monterey Bay Labs ceased to operate in December 2017, becoming an inactive company.
What was the former name of Monterey Bay Labs?
Monterey Bay Labs was formerly known as StarletDerma and NanoCyte.
Where is Monterey Bay Labs headquartered?
Monterey Bay Labs is headquartered in Caesarea, Israel, at Tarshish St 9.
How much funding has Monterey Bay Labs raised in total?
Monterey Bay Labs has raised a total of $9,000,000 USD. For a full financing history, refer to startupim.
When was Monterey Bay Labs' last funding round and what type was it?
Monterey Bay Labs' last funding round was a Series B round in February 2014, raising $9,000,000 USD.
What is the status of Monterey Bay Labs' intellectual property?
Monterey Bay Labs possesses a strong and broad IP portfolio, granted in the United States, Europe, and Asia, covering marine biology, mass cultivation, formulations, and methods for producing micro-injectors for topical delivery.
How many employees did Monterey Bay Labs have?
Monterey Bay Labs had an employee count in the range of 11-50, with an exact count of 31 employees.
What significant collaboration deal did StarletDerma (now Monterey Bay Labs) sign in February 2014?
In February 2014, StarletDerma (Monterey Bay Labs) signed a collaboration deal with L'Oreal for cosmetics.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyCosmetic Materials
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesCosmeticsPharmaceuticalsHealthcarePatients
Business model
B2B

Highlights

1 Patents

Tags

dermatologypharma-companiesacnepharmaceuticalstopical-treatmentpatients